Претраживање
Приказ резултата 1-10 од 60
Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits
(Elsevier Science BV, Amsterdam, 2009)
RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity
(Elsevier Science BV, Amsterdam, 2008)
The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patients
(Elsevier Science BV, Amsterdam, 2010)
Moclobemide dosage regimen adjustment in depressive patients on carbamazepine co-therapy
(Elsevier Science BV, Amsterdam, 2009)
Effects of a novel inverse agonist selective for alpha5 GABAA receptors on spatial memory: comparison with the standard non-selective inverse agonist DMCM
(Elsevier Science BV, Amsterdam, 2008)
Contribution of a1 subunit-containing GABA-A receptors to diazepam-induced motor impairment
(Elsevier Science BV, Amsterdam, 2010)
Efficacy and safety of combined therapy with moclobemide and valproic acid or carbamazepine in depressive patients
(Elsevier Science BV, Amsterdam, 2009)
The involvement of adenosine A1 receptors in the antinociceptive effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia
(Elsevier Science BV, Amsterdam, 2004)
WYS-8, a novel ligand at GABAA receptors: a step forward to linking in vitro with in vivo selectivity?
(Elsevier Science BV, Amsterdam, 2009)
Midazolam impairs acquisition but not consolidation in water maze paradigm
(Elsevier Science BV, Amsterdam, 2010)